Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy

Documenti analoghi

• Infusional etoposide, cyclophosphamide, vincristine, doxorubicin, and prednisone +/- rituximab as first-line therapy for aggressive non-Hodgkin lymphoma
  di: Lamar, Zanetta S., et al.
  Pubblicazione: (2015)
• Etoposide compared with the combination of vincristine, doxorubicin, and cyclophosphamide in the treatment of small cell lung cancer.
  di: McIllmurray, M B, et al.
  Pubblicazione: (1989)
• Treatment of Primary Mediastinal B-Cell Lymphoma With R-CEOP (Rituximab, Cyclophosphamide, Etoposide, Vincristine, and Prednisone)
  di: Cherukuri, Sundar V, et al.
  Pubblicazione: (2021)
• Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin's Lymphoma
  di: Kim, Jong Gwang, et al.
  Pubblicazione: (2004)
• Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
  di: Candelaria, Myrna, et al.
  Pubblicazione: (2021)